Imagine a world where a simple nosebleed could be life-threatening. For many women in Ireland, and around the globe, this isn't a hypothetical scenario – it's their reality. But groundbreaking research happening right now is changing how we understand and treat inherited bleeding disorders, particularly in women. Dr. Michelle Lavin, a consultant haematologist at St James’s Hospital and a researcher at the Royal College of Surgeons in Ireland (RCSI), is at the forefront of this revolution.
Her work focuses on inherited bleeding disorders, conditions passed down through families that cause excessive bleeding. You've probably heard of haemophilia, but von Willebrand disease is another, often overlooked, example. Both share a common thread: they increase the likelihood of problematic bleeding. Dr. Lavin's research digs deep into why so many individuals, especially women, remain undiagnosed or receive inadequate treatment. But here's where it gets controversial... are we, as a society, adequately prioritizing women's health issues, or are these conditions slipping through the cracks due to a lack of awareness and focused research?
So, why are women disproportionately affected by bleeding disorders? The answer, in large part, lies in menstruation. For women with underlying bleeding disorders, periods can become debilitating, leading to dangerously heavy blood loss and impacting their overall health. Think soaking through multiple pads daily, for more than seven days, and needing time off work. Childbirth also presents significant risks. Unmanaged bleeding disorders can result in severe postpartum haemorrhage, putting mothers' lives in danger. Therefore, accurate diagnosis is paramount. And this is the part most people miss... often, women think their extremely heavy periods are "normal" because their mothers or sisters experience the same thing. This normalization prevents them from seeking the medical attention they desperately need.
Fortunately, there are effective treatments available. In cases of haemophilia and von Willebrand disease, the problem often stems from deficient clotting factors – proteins that help the body stop bleeding. We can directly administer these clotting factors to patients, effectively controlling the excessive bleeding. Hormone-based treatments, such as the contraceptive pill, can also be beneficial for managing monthly menstrual bleeding.
Balancing a demanding clinical workload at St James’s Hospital with research at RCSI is no easy feat. Dr. Lavin emphasizes the importance of dedicated research time, seeing it as a crucial investment in improving clinical care. She explains that her roles are complementary, with her work as a consultant haematologist at the National Coagulation Centre informing her research, and vice versa. By reducing her clinical hours to focus on research, grant writing, and conducting studies, Dr. Lavin is able to bring Irish research to international networks, particularly in Europe.
What drives Dr. Lavin's dedication? The potential for real-world impact. "In Ireland, we punch above our weight in diagnosing von Willebrand disease and women with bleeding disorders," she says, crediting the clinical centre and the research at the Irish Centre for Vascular Biology. The Low Von Willebrand in Ireland Cohort study, funded by the Health Research Board, stands as the world's largest dedicated study of patients with low von Willebrand factor. The findings generated in Ireland are actively shaping international practices. This is truly remarkable!
Dr. Lavin wants people to understand that inherited bleeding disorders are likely more common than they realize. They can manifest in seemingly minor symptoms like low haemoglobin or iron levels, leading to fatigue and reduced energy. Many women with undiagnosed bleeding disorders suffer from prolonged, heavy periods, often dismissing them as normal because of family history. To combat this, Dr. Lavin and her team developed a website, knowyourflow.ie, to provide information about heavy menstrual bleeding. If you experience similar symptoms, or if you bleed excessively after surgery or dental work, or have nosebleeds lasting longer than 15 minutes, seeking a referral to a haematologist for blood tests is highly recommended.
In her precious time away from the clinic and lab, Dr. Lavin enjoys a busy family life. She and her husband are devoted to their three children, spending countless hours at dance recitals and swimming pools. Dr. Lavin also has a passion for baking, eagerly contributing to bake sales whenever the opportunity arises.
Dr. Michelle Lavin's work is a testament to the power of research to transform lives. But here's a thought: Should genetic screening for bleeding disorders be more widely implemented, especially for women planning pregnancies? Could this proactive approach prevent unnecessary suffering and potentially life-threatening complications? What are your thoughts? Share your opinions in the comments below!
